In a clinical trial of patients with rheumatoid arthritis, treatment with a drug called upadacitinib provided greater benefits than methotrexate, the most commonly used initial therapy for rheumatoid arthritis.
New trial results question standard treatment plan for rheumatoid arthritis
- EurekAlert
- 8. 7 2020 (06:00)